Search results for "Spirillaceae"

showing 10 items of 15 documents

Previous antibacterial treatment due to concomitant infections in preschool children is associated with a lower Helicobacter pylori positivity

2005

Use of antimicrobial agents has been proposed as 1 of the factors that contribute to the loss of Helicobacter pylori (H. pylori) infection. The aim of the study was to investigate the influence of a previous treatment with antibiotics on the prevalence of H. pylori infection in preschool children. Parents of 146 asymptomatic children (aged 0.5-5 y; no antibiotic treatment during the previous 4 weeks) completed a questionnaire about previous treatment with antibiotics and socioeconomic status. Infection with H. pylori was assessed by the monoclonal stool antigen test. H. pylori positivity was 18% (27/146). It was significantly lower in children who had been treated with antibiotics previousl…

MaleMicrobiology (medical)medicine.medical_specialtymedicine.drug_classSpirillaceaeAntibioticsAsymptomaticHelicobacter InfectionsInternal medicinePrevalencemedicineHumansRespiratory Tract InfectionsAntibacterial agentHelicobacter pyloriGeneral Immunology and Microbiologybiologybusiness.industryInfantGeneral MedicineHelicobacter pyloriAntimicrobialbiology.organism_classificationAnti-Bacterial AgentsInfectious DiseasesEl NiñoChild PreschoolConcomitantImmunologyFemalemedicine.symptombusinessScandinavian Journal of Infectious Diseases
researchProduct

One-step polymerase chain reaction-based typing of Helicobacter pylori vacA gene: association with gastric histopathology.

2000

Heterogeneity of the Helicobacter pylori vacA gene may be associated with bacterial virulence and presentation. In this study, the possible correlation between vacA genotypes and gastric histopathology was investigated. Using a modified one-step polymerase chain reaction (PCR)-based method, 122 of 131 H. pylori isolates obtained from 63 of 67 patients from Germany were classified into distinct vacA genotypes according to their signal sequence (s1 or s2) and their midregion alleles (m1 or m2). A possible subtype of m1, now alluded to as m3, was identified in one-third of the isolates. Signal sequence s1 was significantly associated with higher H. pylori density but not with gastric inflammat…

Microbiology (medical)AdultDNA BacterialMaleAdolescentGenotypeSpirillaceaeImmunologyPeripheral blood mononuclear cellPolymerase Chain ReactionMicrobiologylaw.inventionHelicobacter InfectionsBacterial ProteinslawGenotypemedicineImmunology and AllergyCagAHumansTypingChildPolymerase chain reactionAntigens BacterialbiologyHelicobacter pyloriGeneral MedicineHelicobacter pyloriMiddle Agedbacterial infections and mycosesbiology.organism_classificationdigestive system diseasesBacterial Typing TechniquesGastric MucosaChild PreschoolGastritisFemaleGastritismedicine.symptomMedical microbiology and immunology
researchProduct

Negative Effect of Ranitidine on The Results of Urea Breath Test for The Diagnosis of Helicobacter Pylori

2001

In analogy with proton pump inhibitors, H2-antagonists may also be responsible for false-negative results on urea breath test for the detection of Helicobacter pylori. In this study we assessed the frequency and duration of false-negative urea breath tests in patients given different doses of ranitidine.A total of 120 consecutive dyspeptic patients infected with H. pylori on the basis of concomitant positive results of CLO-test, histology and urea breath test were recruited for this prospective, open, parallel-group study performed in an urban university gastroenterological clinic. They were randomized to receive an acute treatment with either ranitidine 300 mg once a day in the evening, ra…

Malemedicine.medical_specialtyTime FactorsUrea breath testSpirillaceaeRanitidineGastroenterologyHelicobacter InfectionsRanitidinechemistry.chemical_compoundInternal medicinemedicineHumansUreaProspective StudiesDyspepsiaFalse Negative ReactionsBreath testCarbon IsotopesDose-Response Relationship DrugHelicobacter pyloriHepatologymedicine.diagnostic_testbiologybusiness.industrydigestive oral and skin physiologyFalse Negative ReactionsGastroenterologyMiddle AgedHelicobacter pyloribacterial infections and mycosesHelicobacter Infectionsbiology.organism_classificationBreath TestsHistamine H2 AntagonistschemistryUreaFemalebusinessmedicine.drugAmerican Journal of Gastroenterology
researchProduct

Head-to-head comparison of 1-week triple regimens combining ranitidine or omeprazole with two antibiotics to eradicate Helicobacter pylori

1999

Background : Triple therapies containing omeprazole and ranitidine have been shown to be equivalent in eradicating H. pylori infection, but have been assessed either separately or head-to-head, only in small trials. Aim : To carry out a large randomized controlled study comparing omeprazole and ranitidine combined with two antibiotic combinations for 1 week. Methods : Three hundred and twenty H. pylori-positive patients were randomly subdivided into four equal-sized groups and received one of the following treatments: OAM = omeprazole 20 mg b.d. + amoxycillin 1 g b.d. + metronidazole 500 mg b.d.; RAM = ranitidine 300 mg b.d. + amoxycillin 1 g b.d. + metronidazole 500 mg b.d.; OAC = omeprazo…

medicine.medical_specialtyHepatologybiologymedicine.drug_classbusiness.industrySpirillaceaeAntibioticsGastroenterologyProton-pump inhibitorHelicobacter pyloribiology.organism_classificationGastroenterologySurgeryRanitidineClarithromycinInternal medicinemedicinePharmacology (medical)businessOmeprazolemedicine.drugAntibacterial agentAlimentary Pharmacology & Therapeutics
researchProduct

Helicobacter pyloriinfection is not involved in the pathogenesis of either erosive or non-erosive gastro-oesophageal reflux disease

2003

Summary Background : The majority of reflux patients have non-erosive reflux disease. Aim : To evaluate the influence of Helicobacter pylori on oesophageal acid exposure in patients with both non-erosive and erosive reflux disease and in a group of controls. The pattern and distribution of chronic gastritis were also assessed. Methods : One hundred and twelve consecutive patients with symptoms of gastro-oesophageal reflux disease agreed to undergo both upper gastrointestinal endoscopy and 24-h oesophageal pH-metry. Patients were grouped as H. pylori-positive or H. pylori-negative on the basis of both CLO-test and histology, and as cases with or without oesophagitis on the basis of endoscopy…

medicine.medical_specialtyHepatologybiologyEsophageal diseasebusiness.industrySpirillaceaeGastroenterologyRefluxChronic gastritisHelicobacter pyloribiology.organism_classificationmedicine.diseaseGastroenterologymedicine.anatomical_structureInternal medicinemedicinePharmacology (medical)EsophagusGastritismedicine.symptombusinessAntrumAlimentary Pharmacology & Therapeutics
researchProduct

The phenotype of gastric mucosa coexisting with Barrett's oesophagus.

2001

Barrett's oesophagus complicates the gastro-oesophageal acid reflux. Helicobacter pylori infection, particularly with cagA positive strains, induces inflammatory/atrophic lesions of the gastric mucosa, which may impair acid output. No systematic study has investigated the phenotype of the gastric mucosa coexisting with Barrett's oesophagus. This study was designed to identify the phenotype of gastric mucosa associated with Barrett's oesophagus.In this retrospective case control study, the phenotype of the gastric mucosa was histologically characterised in 53 consecutive patients with Barrett's oesophagus and in 53 (sex and age matched) non-ulcer dyspeptic controls. Both patients and control…

AdultGastritis AtrophicMalemedicine.medical_specialtyPathologyAtrophic gastritisBiopsySpirillaceaeBarrett's oesophagus gastritis in Barrett's oesophagus Barrett's oesophagus and gastric precancerous lesionsdigestive systemGastroenterologyHelicobacter InfectionsPathology and Forensic MedicineBarrett's oesophagus and gastric precancerous lesionsBarrett EsophagusInternal medicineotorhinolaryngologic diseasesGastric mucosamedicineHumansCagAAgedRetrospective StudiesAged 80 and overHelicobacter pyloribiologybusiness.industrygastritis in Barrett's oesophagusStomachdigestive oral and skin physiologyIntestinal metaplasiaGeneral MedicineMiddle AgedHelicobacter pyloribiology.organism_classificationmedicine.diseasedigestive system diseasesBarrett's oesophagussurgical procedures operativePhenotypemedicine.anatomical_structureGastric MucosaCase-Control StudiesPapersFemaleGastritismedicine.symptombusiness
researchProduct

Bermanella marisrubri gen. nov., sp. nov., a genome-sequenced gammaproteobacterium from the Red Sea

2009

5 pages, 2 figures, 1 table

OceanospirillaceaeThalassolituusMolecular Sequence DataZoologyBiologyMicrobiologyGenomeSpecies SpecificityBermanella marisrubriGenusRNA Ribosomal 16SGenotypeBotanyIndian OceanPhylogenyEcology Evolution Behavior and Systematicsvisual_art.artworkPhylogenetic treeGeneral Medicine16S ribosomal RNAbiology.organism_classificationPhenotypevisual_artWater MicrobiologyGenome BacterialBacteriaINTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
researchProduct

Neptuniibacter caesariensis gen. nov., sp. nov., a novel marine genome-sequenced gammaproteobacterium.

2007

7 pages, 1 figure, 1 table

DNA BacterialOceanospirillaceaeSequence analysisMovementMolecular Sequence DataCarboxylic AcidsZoologyAlteromonadaceaeMicrobiologyDNA RibosomalMicrobiologyMembrane LipidsPhylogeneticsRNA Ribosomal 16SSequence Homology Nucleic AcidMediterranean SeaSeawaterAmino AcidsEcology Evolution Behavior and SystematicsPhylogenyBase CompositionbiologyPhylogenetic treeAlteromonadaceaeFatty AcidsGenes rRNAGeneral MedicineSequence Analysis DNARibosomal RNAbiology.organism_classification16S ribosomal RNAHalophileBacterial Typing TechniquesRNA BacterialOceanospirillaceaeGammaproteobacteriaGenome BacterialInternational journal of systematic and evolutionary microbiology
researchProduct

Prevalence of virulence-associated genotypes of Helicobacter pylori and correlation with severity of gastric pathology in patients from western Sicil…

2008

In a bacterium like Helicobacter pylori, which is characterized by a recombinant population structure, the associated presence of genes encoding virulence factors might be considered an expression of a selective advantage conferred to strains with certain genotypes and, therefore, a potentially useful tool for predicting the clinical outcome of infections. However, differences in the geographical and ethnic prevalence of the H. pylori virulence-associated genotypes can affect their clinical predictive value and need to be considered in advance. In this study we carried out such an evaluation in a group of patients living in Sicily, the largest and most populous island in the Mediterranean S…

AdultMicrobiology (medical)Settore MED/07 - Microbiologia E Microbiologia ClinicaVirulence FactorsBiopsySpirillaceaeChronic gastritisVirulenceHelicobacter InfectionsMicrobiologyBacterial ProteinsGenotypemedicineHumansCagAGene–environment interactionSicilyAgedHelicobacter pylori Virulence-associated genotypes Gastric pathology ItalyHelicobacter pyloribiologybusiness.industryGene Expression ProfilingGeneral MedicineMiddle AgedHelicobacter pylorimedicine.diseasebiology.organism_classificationInfectious DiseasesGastric MucosaGastritisGastritismedicine.symptombusiness
researchProduct

Treatment of patients with duodenal ulcer positive for helicobacter pylori infection: ranitidine or omeprazole associated with colloidal bismuth subc…

1996

Abstract This study evaluated treatment of patients affected with duodenal ulcer positive for Helicobacter pylori . We compared patients treated with ranitidine plus amoxicillin plus colloidal bismuth subcitrate (n = 20) with patients treated with omeprazole plus amoxicillin plus colloidal bismuth subcitrate (n = 20) with regard to: (1) healing of duodenal ulcer; (2) eradication of H pylori ; and (3) recurrence of ulcer. Baseline and follow-up for 24 months were performed through clinical, laboratory, and endoscopic tests. The ulcer healing rate was 95% in the ranitidine group and 100% in the omeprazole group; the H pylori eradication rate was 90% and 95%, respectively. During follow-up, on…

Pharmacologymedicine.medical_specialtybiologymedicine.drug_classbusiness.industrySpirillaceaeProton-pump inhibitorAmoxicillinHelicobacter pyloribiology.organism_classificationGastroenterologydigestive system diseasesRanitidinemedicine.anatomical_structureInternal medicinemedicineDuodenumPharmacology (medical)businessOmeprazolemedicine.drugAntibacterial agentCurrent Therapeutic Research
researchProduct